This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Smokers Are At High Risk for Low Back Pain, ... Smokers are at high risk for low back pain, and also have higher ... (20 Feb 2019)
Temperatures Rising: Patients Taking ... Patients taking diuretics are often at risk for low potassium ... (20 Feb 2019)
Hormone therapy may increase cardiovascular ... Patients receiving hormone therapy as part of their ... (20 Feb 2019)
Avoiding Selfie Elbow, Texting Thumb Specialists are seeing more and more repetitive stress injuries ... (20 Feb 2019)
Adolescent Female Blood Donors At Risk For ... New public health measures could help protect this vulnerable ... (20 Feb 2019)

New Glaucoma Procedure Performed in Malta

Rate this item
(0 votes)

On the 15th June, a new glaucoma procedure was performed for the first time in Malta, as part of a surgeon training session organised by Allergan. The new XEN implant forms part of Allergan’s Eyecare portfolio distributed by Vivian Corporation.

glaucoma 2

 

XEN is a simple and effective way to treat glaucoma. The implant consists of a small tube 6mm long and the thickness of a human hair, which is inserted into the eye with a pre-packed injector. This reduces the size of the incision needed. XEN is indicated to reduce eye pressure in patients whose glaucoma is not well-managed with eye drops. It is designed to stay in the eye permanently creating a small pathway to drain fluid away to lower pressure inside the eye.

The surgeons and staff first received training on artificial eyes at St. James Eye Clinic by Allergan’s surgical partner, Dr. Evelina Kotseva. The following morning, a total of 5 patients had the new XEN implants inserted into their eyes. These surgeries were performed by Mr. Mario Vella and Mr. Francis Carbonaro, at Mater Dei Hospital. Katrine Agius, Allergan’s Country Lead, said: "It is a very safe and less time-consuming alternative to the more traditional glaucoma surgery. XEN is also more cost-effective than using more than one type of glaucoma eye drops per patient".

Read 3070 times

Vivian

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…